Patent ID: 7217429

Claim:
A tableted oral pharmaceutical dosage form, covered with an enteric coating, consisting of a plurality of units that contain a benzimidazole compound labile in an acid medium as the active principle, comprising: (a) a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle that contain: i) an inert core; ii) an active layer deposited on said inert core i), formed by a benzimidazole compound labile in an acid medium, a non-alkaline water-soluble inert polymer and one or more pharmaceutically acceptable inert excipients; and iii) an intermediate layer consisting of an inert non-alkaline coating formed by a non-alkaline, water-soluble inert polymer and one or more pharmaceutically acceptable inert excipients, with said intermediate layer being disposed over the aforementioned active layer ii) that covers the inert core i); (b) one or more pharmaceutically acceptable inert excipients, of which one or more are compression excipients; and (c) an enteric coating layer that coats the tableted oral pharmaceutical dosage form wherein each of the plurality of units is provided without an individual enteric coating layer.